Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 43 results found. Search for [ Remdesivir not effective ]

Results 1 to 21 of 43
November 20, 2020
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise

PB Jayakumar
October 20, 2020
This drop in COVID-19 spread cases in India comes at a time when the virus is making a comeback in the US, the only country ahead of India in the case of total active cases

October 17, 2020
India participated in the trials too. In a statement issued on Friday, ICMR concluded the same and said there were no benefits of remdesivir in any of the patients

October 16, 2020
The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients

Joe C Mathew
October 7, 2020
Parallel to the WTO proposal, SJM wants India to initiate measures under Section 66 of the Patents Act for the cancelation of the patent on Remdesivir

August 13, 2020
The drug discovery pipeline is a type of computational strategy linked to AI -- a computer algorithm that learns to predict activity through trial and error, improving over time

July 22, 2020
Coronavirus treatment: Patients who were administered Glenmark's FabiFlu saw 40 per cent faster achievement of clinical cure

PB Jayakumar
July 21, 2020
Glenmark says compared to other therapies approved for emergency use in COVID-19 in India, FabiFlu is much more economical and an effective treatment option; DCGI had earlier asked it to clarify on allegation that the drug was unaffordable due to its high pricing

July 18, 2020
Remdesivir is made by Gilead Sciences Inc, which has committed to supplying 500,000 treatment courses of the drug to HHS for distribution to U.S in July, August and September

July 10, 2020
Coronavirus vaccine news update: Serum Institute of India that is producing around four vaccine candidates including the Oxford University-AstraZeneca coronavirus candidate has said that it is expected to launch a candidate by the end of six months

July 8, 2020
\"The idea that this is a dangerous drug is just silly, but if you ask the American people based on the media's coverage of it, that is kind of the state of play right now,\" he said

June 30, 2020
In the US, federal health officials have allocated the limited supply to states, but that agreement with Gilead will end after September

Associated Press
New Delhi, June 29, 2020
The 250,000 treatment courses that the company had donated to the US and other countries will run out in about a week, and the prices will apply to the drug after that

New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough

E Kumar Sharma
New Delhi, June 27, 2020
\"Remdesavir seems to be useful for those who are coping with the beginning part of the disease and dexamethasone is useful for those who have to deal with the disease in its later phase within the body\"

June 25, 2020
Even with no existing approved vaccines, CEPI is already getting manufacturing and supply chains lined up in a quest to ensure coronavirus vaccines are distributed equitably around the globe

New Delhi, June 18, 2020
Coronavirus vaccine update: Germany's CureVac AG has received approval from the government to conduct human trials. The coronavirus vaccine candidate would first be tested 168 health people according to the government

June 16, 2020
Coronavirus vaccine update: British drugmaker AstraZeneca has reached a deal with New Jersey-based Catalent to help with the final stages of the manufacturing of coronavirus vaccine

New Delhi, June 15, 2020
Coronavirus vaccine update: The Health Ministry has included the use of antiviral drug Remdesivir as part of its investigational therapy for restricted emergency use

June 10, 2020
In China, an activated experimental corona vaccine developed by scientists  has shown effective protection against COVD-19 infection in animal trials

PAGES 1 OF 3  123